Emmanuel Pinard
Basel, BS 4070, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Discovery of a Potent SARM1 Base-Exchange Inhibitor with In Vivo Efficacy.
Journal: Journal of medicinal chemistry
Published: March 18, 2025
Discovery of Orally Available and Brain Penetrant AEP Inhibitors.
Journal: Journal of medicinal chemistry
Published: December 13, 2023
Discovery of Balovaptan, a Vasopressin 1a Receptor Antagonist for the Treatment of Autism Spectrum Disorder.
Journal: Journal of medicinal chemistry
Published: January 18, 2020
Glycine Transporter Type I (GlyT1) Inhibitor, Bitopertin: A Journey from Lab to Patient.
Journal: Chimia
Published: August 31, 2018
Discovery of Risdiplam, a Selective Survival of Motor Neuron-2 ( SMN2) Gene Splicing Modifier for the Treatment of Spinal Muscular Atrophy (SMA).
Journal: Journal of medicinal chemistry
Published: July 26, 2018
Applications of organocatalysed visible-light photoredox reactions for medicinal chemistry.
Journal: Beilstein journal of organic chemistry
Published: May 05, 2018
Discovery of a Novel Class of Survival Motor Neuron 2 Splicing Modifiers for the Treatment of Spinal Muscular Atrophy.
Journal: Journal of medicinal chemistry
Published: April 26, 2017
Specific Correction of Alternative Survival Motor Neuron 2 Splicing by Small Molecules: Discovery of a Potential Novel Medicine To Treat Spinal Muscular Atrophy.
Journal: Journal of medicinal chemistry
Published: June 15, 2016
A Real-World Perspective on Molecular Design.
Journal: Journal of medicinal chemistry
Published: February 16, 2016
3-Amido-3-aryl-piperidines: A Novel Class of Potent, Selective, and Orally Active GlyT1 Inhibitors.
Journal: ACS medicinal chemistry letters
Published: January 06, 2014
β-Secretase (BACE1) inhibitors with high in vivo efficacy suitable for clinical evaluation in Alzheimer's disease.
Journal: Journal of medicinal chemistry
Published: April 18, 2013
Last Updated: 09/26/2026